London Summit 2016

London Summit 2016

What Does Brexit Mean for Health Care and Medical Research?

Tuesday, December 6, 2016 / 11:30 am - 12:30 pm

A new spirit of cooperation is propelling advances in medical research and improving health care. Parties who have traditionally viewed one another primarily as competitors, funders, suppliers or customers are joining forces to improve efficiency and leverage diverse perspectives. The result is more innovative medical products and better care. In this session, panelists will share how government and industry are collaborating, and they will report on progress in the movement to make patients partners in product development and care delivery. Panelists will explain why this matters for all of us and how this collaboration will advance precision medicine.


Margaret Anderson

Executive Director, FasterCures, a Center of the Milken Institute


Aisling Burnand

Chief Executive, Association of Medical Research Charities

Annalisa Jenkins

CEO, Dimension Therapeutics

Pierre Meulien

Executive Director, Innovative Medicines Initiative

Isabelle Moulon

Head of Public Engagement Department, European Medicines Agency

Return to Program Detail